![]() |
市場調查報告書
商品編碼
1675711
RFID 血液冰箱和冷凍櫃市場報告,按類型(RFID 冰箱、RFID 冷凍櫃)、應用(醫院和診斷中心、血庫等)和地區分類,2025 年至 2033 年RFID Blood Refrigerators and Freezers Market Report by Types (RFID Refrigerators, RFID Freezers), Applications (Hospitals and Diagnostic Centers, Blood Banks, and Others), and Region 2025-2033 |
2024 年,全球 RFID 血液冰箱和冷凍機市場規模達到 3.319 億美元。 展望未來, IMARC Group預計到 2033 年市場規模將達到 10.699 億美元,2025-2033 年期間的成長率 (CAGR) 為 13.19%。
無線射頻識別(RFID)血液冰箱和冷凍櫃是指先進的溫控儲存系統,用於收集和安全保存各種試劑和血液成分,包括血漿衍生物和紅血球(RBC)。它們包括互連的管道、毛細管、冷凝器、膨脹器、蒸發器、電動壓縮機和有助於調節冰箱溫度的恆溫器。一些先進的型號還包括配置、壓縮機、電動馬達和緊急電源系統,以便在波動期間提供能源備份。 RFID 血液冰箱和冷凍機可以即時追蹤關鍵的血小板成分及其狀況,並保持產品品質符合食品藥物管理局 (FDA) 的規定。除此之外,它們還聰明、安全、可靠,有助於最大限度地減少技術錯誤並提高營運效率。因此,醫院和診斷中心使用 RFID 血液冰箱和冷凍機來儲存血液,以進行檢測、儲存、運輸和輸血。
推動市場成長的主要因素是白血病、地中海型貧血和血友病等各種慢性疾病的發生率不斷上升以及術後失血發生率的上升。同時,醫院血庫對獲取血漿、樣本和血小板進行實驗和評估細胞功能的需求不斷增加,這促進了市場對該產品的需求。此外,配備由耐腐蝕鋼和手柄製成的抽屜架的先進血液冰箱和冷凍櫃的出現也是另一個促進成長的因素。此類產品包括身份證夾,可以儲存過量的血管,並且無需移除整個架子即可取出。此外,政府和非政府組織 (NGO) 不斷推出措施和提高意識計劃,向大眾宣傳捐血的好處和誤解,這也有利於市場的成長。除此之外,醫療保健基礎設施的顯著改善、持續的研究和開發(R&D)活動以及持續的產品改進和多樣化正在積極刺激市場成長。
本報告也研究了產業競爭格局以及主要參與者的概況,包括 Angelantoni Life Science Srl、Biomed Global、Cardinal Health Inc.、IQM AS、MedSella (MedFlow Clinical Ltd.)、Qingdao Haier Biomedical Co Ltd.、Rollex Group Australia PTY Ltd.、SATO 這些 Corporation Ltd. Venture Research Inc. 請注意,這僅代表部分公司列表,完整列表已在報告中提供。
The global RFID blood refrigerators and freezers market size reached USD 331.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,069.9 Million by 2033, exhibiting a growth rate (CAGR) of 13.19% during 2025-2033.
Radio frequency identification (RFID) blood refrigerators and freezers refer to advanced temperature-controlled storage systems that collect and safely preserve various reagents and blood components, including plasma derivatives and red blood cells (RBCs). They encompass interconnected tubing, a capillary tube, a condenser, expansion, an evaporator, electrically powered compressors, and a thermostat that helps regulate refrigerator temperature. Some advanced models further comprise configurations, compressors, motors, and emergency power systems to provide energy backup during fluctuations. RFID blood refrigerators and freezers allow real-time tracking of critical platelet components and their conditions and maintain the product quality to comply with food and drug administration (FDA) regulations. Apart from this, they are intelligent, safe to use, and reliable and aid in minimizing technical errors and increasing operational efficiency. As a result, RFID blood refrigerators and freezers are used by hospitals and diagnostic centers to store blood for testing, storing, transporting, and transfusion purposes.
The increasing prevalence of various chronic diseases, including leukemia, thalassemia, and hemophilia, and the rising incidences of blood loss post-surgical procedures are primarily driving the market growth. In line with this, the escalating need for blood banks in hospital settings to obtain plasma, samples, and platelets for conducting experiments and assessing cell functions is facilitating the product demand in the market. Additionally, the advent of advanced blood refrigerators and freezers with drawer racks composed of corrosion-resistant steel and handles is acting as another growth-inducing factor. Such products consist of identification cardholders, and they enable the storage of blood tubes in excessive amounts and their retrieval without the removal of the entire rack. Moreover, increasing initiatives and awareness programs by governments and non-governmental organizations (NGOs) toward educating the masses on the benefits and misconceptions of blood donation are favoring the market growth. Apart from this, significant improvements in the healthcare infrastructure, ongoing research and development (R&D) activities, and continuous product enhancements and diversification are positively stimulating the market growth.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Angelantoni Life Science Srl, Biomed Global, Cardinal Health Inc., IQM AS, MedSella (MedFlow Clinical Ltd.), Qingdao Haier Biomedical Co Ltd., Rollex Group Australia PTY Ltd., SATO Vicinity Pty Ltd. (SATO Holdings Corporation), Spacecode Technologies, Terso Solutions Inc. (Promega Corporation), Thalheimer Kuhlung GmbH & Co KG and Venture Research Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.